A PHASE IB CLINICAL STUDY WITH 18F-FDG-PET RESPONSE EVALUATION OF THE COMBINATION OF TEMSIROLIMUS (T) AND PEGYLATED LIPOSOMAL DOXORUBICIN (PLD) IN BREAST, ENDOMETRIAL AND OVARIAN CANCER
Abstract
Data di Pubblicazione:
2012
Tipologia CRIS:
1.5 Abstract in rivista
Elenco autori:
Sonderen, Mj; Desar, Ime; De Geus-Oei, L; van der Graaf, Wta; Oyen, W; Ottevanger, Pb; van Herpen, Cml
Link alla scheda completa:
Pubblicato in: